Failure of Hyped Kidney Drug Trial Reveals Major Flaw in Allopathic Medicine

'A trial expected to demonstrate the drug sulodexide’s ability to halt kidney failure was a disaster for Keryx Pharmaceuticals, the manufacturer. Keryx funded the international trial, anticipating that it would be a major success. By the typical way that allopathic medicine addresses health issues, it should have been. Its failure reveals a gaping flaw in much of allopathic medicine’s approach to both healing and drug approvals.

Sulodexide had been trialed, seemingly successfully, over more than a decade. It had been shown to significantly reduce albuminaria, protein in the urine, which has long been recognized as an important marker for nephropathy—kidney damage and failure. It was even shown to be effective for an extended period after use. So, Keryx took the step that should always be taken in drugs. They attempted to see if it actually prevented kidney failure itself. It didn’t.

What went wrong?

Read more...

• About
• Twitter
• Facebook
• Google+

Unknown

Iam Raju Al Nima From healtheverydays
Find out health informations update, beauty care,fitness energizing moves, easy recipes, expert tips, and advice on losing weight from healtheverydays

Likes

Dislikes

Share

?

@healthhotnews

new Health articles

Raju Al Nima

Posted by Unknown Posted on 23.34 with No comments